Stereotactic Aspiration in Combination with Urokinase Thrombolytic Therapy in Patients with Moderate Thalamic Hemorrhage : a Controlled Trial
CHEN Mao-gang,YIN Qin,ZHU Wu-sheng,WANG Qi-zhang,HUANG Xian-jun,ZHANG Min,JIANG Yong-jun,LI Yong-kun,FAN Xin-ying,MA Min-min,ZUO Qi-long,ZHOU Yi,HUANG Xiao-peng,XU Ge-lin,LIU Xin-feng
2012-01-01
Abstract:Objective To assess the efficacy of stereotactic aspiration in combination with urokinase thrombolytic therapy in patients with moderate(10～35 mL) thalamic hemorrhage(TH). Methods A total of 137 patients with moderate TH admitted to Yancheng First People's Hospital between January 2006 and June 2011 were assigned to receive internal medicine treatment alone(internal medicine treatment group,n=68) or in combination with stereotactic aspiration and urokinase thrombolytic therapy(operation group,n=69),respectively. Results At day 30,operation group was associated with significantly lower mortality rate than that in internal medicine treatment group(10.1% vs 33.8%,P=0.001).Higher mean ranking of Glasgow Outcome Score(GOS) at day 30 was in favor of operation group,but not internal medicine treatment group(P=0.025).Of all survival cases,operation group yielded a considerably reduced National Institute of Health Stroke Scale(NIHSS) than internal medicine treatment group at day 30(13.5±4.0 vs 16.8±4.3,P0.001).Operation group was associated with marked reduction in the volume of hematoma when compared with internal medicine treatment group at day 3(40.1% vs-0.21%,P0.01) and day 7(63.8% vs 39.80%,P0.01).In patients having 10～20 mL TH,operation group resulted in markedly declined NIHSS(8.5±3.9 vs 11.5±4.2,P=0.023),but not mortality or GOS at day 30.In patients with TH of 21～35 mL,lower mortality rate(P0.001) was found in operation group(20/44,45.5%),but not internal medicine treatment group(6/48,12.5%).At day 30,operation group yielded remarkably increased mean ranking of GOS(P0.0001).Of all survival cases,considerably reduced NIHSS was found in operation group when compared with internal medicine treatment group(15.9±3.8 vs 21.4±4.3).Regarding long-term efficacy,significantly elevated mean ranking of GOS was revealed in operation group at day 90(P=0.001).Operation group was associated with a considerably higher rate of preferable(GOS3) prognosis [36/69(52.2%) vs 19/68(27.9%),P=0.001] and markedly reduced cumulative mortality [6/69(13.0%) vs 25/68(36.8%),P=0.001] at day 90 as compared with internal treatment group.In patients with 10～20 mL TH,both groups did not differ statistically in terms of mean ranking of GOS,preferable prognosis rate and mortality at day 90(all P0.05).Contrarily,in patients with 21～35 mL TH,operation group yielded significantly higher mean ranking of GOS(P=0.001) and preferable prognosis rate [20/48(41.7%) vs 6/44(13.6%),P=0.003] as well as considerably reduced cumulative mortality at day 90 [8/48(16.7%) vs 22/44(50.0%),P=0.001].However,the distinction in incidence rate of recurrent hemorrhage,intracranial infection and pulmonary infection in both groups did not reach statistical significance at day 30(P0.05). Conclusion Stereotactic aspiration in combination with urokinase thrombolytic therapy is effective and safe for patients with moderate TH and may be worthwhile for popularization in clinics despite the fact that further investigation in large-scale,randomized,controlled trials may be required.